Indication

Keratoderma

Keratoderma refers to a heterogeneous group of dermatologic conditions characterized by marked, abnormal thickening and hyperkeratosis of the stratum corneum, most predominantly involving the epidermis of the palms and soles. Read more about Keratoderma

36 drugs 30 manufacturers

Advertisement

Drugs that treat it

Common Keratoderma therapies.

Showing 1–9 of 36 drugs

Filter & compare in the drug finder →Opens the drug finder with Keratoderma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Keratoderma.

Keratoderma refers to a heterogeneous group of dermatologic conditions characterized by marked, abnormal thickening and hyperkeratosis of the stratum corneum, most predominantly involving the epidermis of the palms and soles.

It affects pediatric and adult populations and presents in diffuse, focal, or punctate morphological patterns that may be strictly confined to volar surfaces or exhibit transgradient extension.

Pathophysiologically, keratodermas can be hereditary—arising from mutations disrupting epidermal differentiation, mechanical integrity, intercellular adhesion, or gap junctions—or acquired secondary to inflammatory dermatoses, malignancies, systemic diseases, or adverse drug reactions.

Defining clinical features include yellowish, thickened hyperkeratotic plaques often complicated by painful fissuring, desquamation, contractures, and secondary bacterial or fungal infections.

Personalize your experience

Follow Keratoderma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it